Authors: Castellani, MR Chiti, A Seregni, E Bombardieri, E

Citation: Mr. Castellani et al., Role of I-131-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours - Experience of the National Cancer Institute of Milan, Q J NUCL M, 44(1), 2000, pp. 77-87

Authors: Maffioli, L Belli, F Gallino, G Ditto, A Castellani, MR Testoni, M Sturm, E Bombardieri, E Cascinelli, N

Citation: L. Maffioli et al., Sentinel node biopsy in patients with cutaneous melanoma of the head and neck, TUMORI, 86(4), 2000, pp. 341-342

Authors: Chiti, A van Graafeiland, BJ Savelli, G Ferrari, L Seregni, E Castellani, MR Bombardieri, E

Citation: A. Chiti et al., Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues, ITAL J GAST, 31, 1999, pp. S190-S194

Authors: Maffioli, LS Castellani, MR Bombardieri, E Devizzi, L Draisma, A Pauwels, E

Citation: Ls. Maffioli et al., Changing biodistribution of gallium during G-CSF treatment in non-Hodgkin's disease, EUR J NUCL, 26(1), 1999, pp. 68-69

Authors: Colombo, C Crosignani, A Battezzati, PM Castellani, MR Comi, S Melzi, ML Giunta, A

Citation: C. Colombo et al., Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease, J HEPATOL, 31(4), 1999, pp. 672-677